Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19
Creator
Kluge, Stefan
Bauer, Torsten
Ewig, Santiago
Windisch, Wolfram
Pfeifer, Michael
Voshaar, Thomas
Dellweg, Dominic
Geiseler, Jens
Heckeshorn,
Lepper, Philipp
Randerath, Winfried
Schönhofer, Bernd
Torsten Bauer, Lungenklinik
Westhoff, Michael
source
Medline; PMC
abstract
Against the background of the pandemic caused by infection with the SARS-CoV-2 virus, the German Respiratory Society has appointed experts to develop therapy strategies for COVID-19 patients with acute respiratory failure (ARF). Here we present key position statements including observations about the pathophysiology of (ARF). In terms of the pathophysiology of pulmonary infection with SARS-CoV-2, COVID-19 can be divided into 3 phases. Pulmonary damage in advanced COVID-19 often differs from the known changes in acute respiratory distress syndrome (ARDS). Two types (type L and type H) are differentiated, corresponding to early- and late-stage lung damage. This differentiation should be taken into consideration in the respiratory support of ARF. The assessment of the extent of ARF should be based on arterial or capillary blood gas analysis under room air conditions, and it needs to include the calculation of oxygen supply (measured from the variables of oxygen saturation, hemoglobin level, the corrected values of Hüfner's factor, and cardiac output). Aerosols can cause transmission of infectious, virus-laden particles. Open systems or vented systems can increase the release of respirable particles. Procedures in which the invasive ventilation system must be opened and endotracheal intubation carried out are associated with an increased risk of infection. Personal protective equipment (PPE) should have top priority because fear of contagion should not be a primary reason for intubation. Based on the current knowledge, inhalation therapy, nasal high-flow therapy (NHF), continuous positive airway pressure (CPAP), or noninvasive ventilation (NIV) can be performed without an increased risk of infection to staff if PPE is provided. A significant proportion of patients with ARF present with relevant hypoxemia, which often cannot be fully corrected, even with a high inspired oxygen fraction (FiO2) under NHF. In this situation, the oxygen therapy can be escalated to CPAP or NIV when the criteria for endotracheal intubation are not met. In ARF, NIV should be carried out in an intensive care unit or a comparable setting by experienced staff. Under CPAP/NIV, a patient can deteriorate rapidly. For this reason, continuous monitoring and readiness for intubation are to be ensured at all times. If the ARF progresses under CPAP/NIV, intubation should be implemented without delay in patients who do not have a “do not intubate” order.
has issue date
2020-06-19
(
xsd:dateTime
)
bibo:doi
10.1159/000509104
bibo:pmid
32564028
has license
no-cc
sha1sum (hex)
a07e4d7cb22de0fd5f0e13778e598237082fced3
schema:url
https://doi.org/10.1159/000509104
resource representing a document's title
Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19
has PubMed Central identifier
PMC7360514
has PubMed identifier
32564028
schema:publication
Respiration
resource representing a document's body
covid:a07e4d7cb22de0fd5f0e13778e598237082fced3#body_text
is
schema:about
of
named entity 'Position'
named entity 'Patients'
named entity 'CAUSED BY'
named entity 'BACKGROUND'
named entity 'INFECTION'
named entity 'infection'
named entity 'State-of-the-Art'
named entity 'CAP'
named entity 'viral infection'
named entity 'saline solution'
named entity 'FFP2'
named entity 'COVID-19'
named entity 'invasive ventilation'
named entity 'clinical situation'
named entity 'shortness of breath'
named entity 'infection'
named entity 'single-hose'
named entity '2.1'
named entity 'Berlin'
named entity 'Sars-CoV-2'
named entity 'pneumonia'
named entity 'inflammation'
named entity '49, 50'
named entity 'NIV'
named entity 'comorbidity'
named entity 'hypoxic pulmonary vasoconstriction'
named entity 'ARDS'
named entity 'interleukin (IL)-6'
named entity 'virus'
named entity 'Canada'
named entity 'ARDS'
named entity 'procalcitonin'
named entity 'personalized medicine'
named entity 'fomite'
named entity 'viruses'
named entity 'ICUs'
named entity 'virus'
named entity 'medical care'
named entity 'invasive ventilation'
named entity 'dyspnea'
named entity 'dyspnea'
named entity '2.25'
named entity 'COVID-19'
named entity 'medical care'
named entity 'respiratory insufficiency'
named entity 'ICU'
named entity 'CPAP'
named entity 'ARDS'
named entity 'aminopeptidase'
named entity 'COVID-19'
named entity 'aerosol'
named entity 'hemoglobin'
named entity 'NIV'
named entity 'NIV'
named entity 'IL-6'
named entity 'IL-7'
named entity 'organ dysfunction'
named entity 'risk factor'
named entity 'ARDS'
named entity 'CRP'
named entity 'arrhythmia'
named entity 'healthcare workers'
named entity 'NIV'
named entity 'thromboembolic'
named entity 'Evidence-Based Medicine'
named entity 'median aerodynamic diameter'
named entity 'chest X-ray'
named entity 'sepsis'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 11
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software